Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cynosure Inc (NASDAQ:CYNO)

48.37
Delayed Data
As of May 27
 +0.59 / +1.23%
Today’s Change
29.00
Today|||52-Week Range
51.59
+8.28%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$1.2B

Company Description

Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis, reduce the appearance of cellulite and treat toenail fungus. It offers single energy source systems as well as workstations that incorporate two or more different types of lasers or pulsed light technologies. The company also offers multiple technologies and system alternatives at a variety of price points depending primarily on the number and type of energy sources included in the system. Cynosure was founded on July 10, 1991 and is headquartered in Westford, MA.

Contact Information

Cynosure, Inc.
5 Carlisle Road
Westford Massachusetts 01886
P:(978) 256-4200
Investor Relations:

Employees

Shareholders

Other institutional58.72%
Mutual fund holders42.86%
Individual stakeholders14.53%

Top Executives

Michael R. DavinChairman & Chief Executive Officer
Timothy W. BakerPresident, Chief Financial & Operating Officer
Peter C. AnastosSecretary, Senior Vice President & General Counsel
Chris AronsonVice President-North American Sales
Douglas J. DelaneyExecutive Vice President-Worldwide Sales